Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Store away from light
Inflammopharmacology 19 (3), 155167
Tirzepatide is not a GLP-1 receptor agonist monotherapy but is a major incretin competitor (dual GIP/GLP-1)
Individuals who are not enrolled in a clinical trial but have accessed retatrutide through other means should be aware that the medication is unlicensed in the UK
Pharmacies that conduct their own stability studies can typically assign longer BUDs (60-120 days)
Use an insulated bag with cooling packs to keep your medication at the right temperature
US$ 28.52
US$ 22.02
US$ 21.34
US$ 29.67
US$ 22.80
US$ 26.94
US$ 28.24
